Dephosphorylation of Rb (Thr-821) in response to cell stress

Experimental Cell Research

Volumn 312, Issue 15, 2006, Pages 2757-2763

  Krucher, Nancy A ^a   Rubin, Ethel ^b   Tedesco, Vivienne C ^c   Roberts, Michael H ^a   Sherry, Tara C ^a   De Leon, Gabriel ^a  

^a PACE UNIVERSITY   (United States)

^b Biofortis Inc   (United States)

^c MCMASTER UNIVERSITY   (Canada)

Author keywords

Hypoxia; PNUTS; PP1; Rb phosphorylation

Indexed keywords

CYTARABINE; PHOSPHATASE; PHOSPHOPROTEIN PHOSPHATASE 1; RETINOBLASTOMA PROTEIN; THREONINE;

ANIMAL CELL; ARTICLE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL DIVISION; CELL HYPOXIA; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME SUBUNIT; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; WESTERN BLOTTING;

ARA;

EID: 33747339919     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexcr.2006.05.002     Document Type: Article

References (36)

1. Broceno C., Wilkie S., and Mittnacht S. RB activation defect in tumor cell lines. Proc. Natl. Acad. Sci. 99 (2002) 14200-14205
2. Mittnacht S. The retinoblastoma protein-from bench to bedside. Eur. J. Cell Biol. 84 (2005) 97-107
3. Sherr C.J., and McCormick F. The RB and p53 pathways in cancer. Cancer Cell 2 (2002) 103-112
4. Sellers W.R., Novitch B.G., Miyake S., Heith A., Otterson G.A., Kaye F.J., Lassar A.B., and Kaelin W.G. Stable binding of E2F is not required for the retinoblastoma protein to activate transcription, promote differentiation, and suppress tumor cell growth. Genes Dev. 12 (1998) 95-106
5. Buckovich K., Duffy L.A., and Harlow E. The retinoblastoma protein is phosphorylated during specific phases of the cell cycle. Cell 58 (1989) 1097-1105
6. Decaprio J.A., Ludlow J.W., Lynch D., Furukawa Y., Griffin J., Piwnica-Worms H., Huang C.-M., and Livingston D.M. The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element. Cell 58 (1989) 1085-1095
7. Morris E.J., and Dyson N.J. Retinoblastoma protein partners. Adv. Cancer Res. 82 (2001) 1-54
8. Nevins J.R., Leone G., DeGregori J., and Jakoi L. Role of the Rb/E2F pathway in cell growth control. J. Cell. Physiol. 173 (1997) 233-236
9. Harbour J.W., and Dean D.C. The Rb/E2F pathway: expanding roles and emerging paradigms. Genes Dev. 14 (2000) 2393-2409
10. Frolov M.V., and Dyson N.J. Molecular mechanisms of E2F-dependent activation and pRB-mediated repression. J. Cell Sci. 117 (2004) 2173-2181
11. Barrientes S., Cooke C., and Goodrich D.W. Glutamic acid mutagenesis of retinoblastoma protein phosphorylation sites has diverse effects on function. Oncogene 19 (2000) 562-570
12. Knudsen E.S., and Wang J.Y.J. Differential regulation of retinoblastoma protein function by specific cdk phosphorylation sites. J. Biol. Chem. 271 (1996) 8313-8320
13. Knudsen E.S., and Wang J.Y.J. Hyperphosphorylated p107 and p130 bind to T-antigen: identification of a critical regulatory sequence present in RB but not in p107/p130. Oncogene 16 (1998) 1655-1663
14. Nelson D.A., Krucher N.A., and Ludlow J.W. High molecular weight protein phosphatase type 1 dephosphorylates the retinoblastoma protein. J. Biol. Chem. 272 (1997) 4528-4535
15. Stauss M., Lukas J., and Bartek J. Unrestricted cell cycling and cancer. Nat. Med. 1 (1995) 1245-1246
16. Ludlow J.W., Glendening C.L., Livingston D.M., and DeCaprario J.A. Specific enzymatic dephosphorylation of the retinoblastoma protein. Mol. Cell. Biol. 13 (1993) 367-372
17. Berndt N. Roles and regulation of serine/threonine specific protein phosphatases in the cell cycle. Prog. Cell Cycle Res. 5 (2003) 497-510
18. Rubin E., Mittnacht S., Villa-Moruzzi E., and Ludlow J.W. Site-specific and temporally regulated retinoblastoma protein dephosphorylation by protein phosphatase type 1. Oncogene 20 (2001) 3776-3785
19. Krtolica A., Krucher N.A., and Ludlow J.W. Hypoxia-induced pRb hypophosphorylation results from downregulation of CDK and upregulation of PP1 activities. Oncogene 17 (1998) 2295-2304
20. Krtolica A., Krucher N.A., and Ludlow J.W. Molecular analysis of selected cell cycle regulatory proteins during aerobic and hypoxic maintenance of human ovarian carcinoma cells. Br. J. Cancer 80 (1999) 1875-1883
21. Kreivi J.-P., Trinkle-Mulcahy L., Lyon C.E., Morrice N.A., Cohen P., and Lamond A.I. Purification and characterisation of p99, a nuclear modulator of protein phosphatase activity. FEBS Lett. 420 (1997) 57-62
22. Allen P.B., Kwon Y.-G., Nairn A.C., and Greengard P. Isolation and characterization of PNUTs, a putative protein phosphatase 1 nuclear targeting subunit. J. Biol. Chem. 273 (1998) 4089-4095
23. Kim Y.-M., Watanabe T., Allen P.B., Kim Y.-M., Lee S.-J., Greengard P., Nairn A.C., and Kwon Y.-G. PNUTS, a protein phosphatase 1 (PP1) nuclear targeting subunit, characterization of its PP1- and RNA-binding domains and regulation by phosphorylation. J. Biol. Chem. 278 (2003) 13819-13828
24. Udho E., Tedesco V.C., Zygmunt A., and Krucher N.A. PNUTS (phosphatase nuclear targeting subunit) inhibits retinoblastoma-directed PP1 activity. Biochem. Biophys. Res. Commun. 297 (2002) 463-467
25. Pavletich N.P. Mechanisms of cyclin-dependent kinase regulation: structures of cdks, their cyclin activators, and cip and INK4 inhibitors. J. Mol. Biol. 287 (1999) 821-828
26. Malumbres M., and Barbacid M. To cycle or not to cycle: a critical decision in cancer. Nat. Rev., Cancer 1 (2001) 222-231
27. Pardee A.B. G1 events and regulation of cell proliferation. Science 246 (1989) 603-608
28. Berndt N., Dohadwala M., and Liu C.W.Y. Constitutively active protein phosphatase 1 α causes Rb-dependent G1 arrest in human cancer cells. Curr. Biol. 7 (1997) 375-386
29. Dou Q.P., An B., and Will P.L. Induction of a retinoblastoma phosphatase by anticancer drugs accompanies p53-independent G1 arrest and apoptosis. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 9019-9023
30. Ludlow J.W., Nelson D.A., and Krucher N.A. Use of immunocomplexed substrate for detecting PP1 activity. Methods Mol. Biol. 93 (1998) 137-143
31. Zygmunt A., Tedesco V.C., Udho E., and Krucher N.A. Hypoxia stimulates p16 expression and association with cdk4. Exp. Cell Res. 278 (2002) 53-60
32. Campos M., Fadden P., Alms G., Qian Z., and Haystead T.A.J. Identification of protein phosphatase-1-binding proteins by Microcystin-Biotin Affinity Chromatography. J. Biol. Chem. 271 (1996) 28478-28484
33. Dohadwala M., Da Cruz e Silva E.F., Hall F.L., Williams R.T., Carbonaro-Hall D.A., and Nairn A.C. Phosphorylation and inactivation of protein phosphatase 1 by cyclin dependent kinases. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 6408-6412
34. Kwon Y.G., Lee S.Y., Choi Y., Greengard P., and Nairn A.C. Cell cycle dependent phosphorylation of mammalian protein phosphatase 1 by cdc kinase. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 2168-2173
35. Liu C.W., Wang R.H., Dohadwala M., Schonthal A.H., Villa-Moruzzi E., and Berndt N. Inhibitory phosphorylation of PP1 alpha catalytic subunit during the G1/S transition. J. Biol. Chem. 274 (1999) 29470-29475
36. Nelson D.A., and Ludlow J.W. Characterization of the mitotic phase pRb-directed protein phosphatase activity. Oncogene 14 (1997) 2407-2415